Cypress, TX News – Houston Methodist Willowbrook Hospital among First Hospitals in Texas to Implant Reveal LINQ™ ICM Miniature Cardiac Monitor

Cypress, TX News (June 5, 2014) - Houston Methodist Willowbrook Hospital is one of the first hospitals in Texas to implant the Medtronic Reveal LINQ Insertable Cardiac Monitor (ICM) System in a patient. The Reveal LINQ ICM is the smallest implantable cardiac monitoring device available on the market, approximately one-third the size of a AAA battery, making it more than 80 percent smaller than other ICMs. Although small in size, the device is part of a powerful system that allows physicians to continuously and wirelessly monitor a patient’s heart for up to three years.

Interventional cardiologist Sanjay Kunapuli, MD, with Houston Methodist DeBakey Cardiology Associates, successfully completed the first implant at Houston Methodist Willowbrook Hospital in late April 2014. With a history of syncope (fainting), the patient was an excellent candidate. Syncope is generally related to temporary insufficient blood flow to the brain and often occurs when blood pressure is too low and the heart doesn’t pump a normal supply of oxygen to the brain.

“The LINQ system is the next generation of implantable heart monitors,” says Dr. Kunapuli. “In addition to being small and hardly visible, the system is very effective because of its simplicity for patients. Data is transmitted continuously which improves the ability to detect cardiac arrhythmias and trend data.”

Interventional cardiologist Sanjay Kunapuli, MD 

In addition to its continuous and wireless monitoring capabilities, the system provides remote monitoring through the Carelink® Network, which can alert physicians if their patients have had cardiac events.

The Reveal LINQ ICM is indicated for patients who experience symptoms such as dizziness, palpitation, syncope, and chest pain that may suggest a cardiac arrhythmia, and for patients at increased risk for cardiac arrhythmias. Implanted using a minimally invasive procedure, the ICM is placed just beneath the skin through a small incision of less than one centimeter in the upper left side of the chest and is often nearly invisible to the naked eye once inserted. Patients with the Reveal LINQ ICM can still undergo magnetic resonance imaging (MRI) if needed.

The Reveal LINQ system also includes the new MyCareLink ™ Patient Monitor, a simplified remote monitoring system with global cellular technology that transmits patients’ cardiac device diagnostic data to their clinicians from nearly any location in the world.

“This device has the potential to help many different patients,” said Dr. Kunapuli. “If someone has symptoms that may be due to an underlying heart rhythm problem, this device may help us find answers and develop an effective plan of care.”